Susceptibility evaluation of novel beta-lactam/beta-lactamase inhibitor combinations against carbapenem-resistant Klebsiella pneumoniae from bloodstream infections in hospitalized patients in Brazil
-
Published:2024-09
Issue:
Volume:38
Page:247-251
-
ISSN:2213-7165
-
Container-title:Journal of Global Antimicrobial Resistance
-
language:en
-
Short-container-title:Journal of Global Antimicrobial Resistance
Author:
Wilhelm Camila MörschbächerORCID,
Antochevis Laura Czerkster,
Magagnin Cibele Massotti,
Arns BeatrizORCID,
Vieceli Tarsila,
Pereira Dariane CastroORCID,
Lutz LarissaORCID,
de Souza Ândrea CelestinoORCID,
dos Santos Jéssica Nesello,
Guerra Rafaela RamalhoORCID,
Medeiros Gregory S.ORCID,
Santoro LucasORCID,
Falci Diego R.,
Rigatto Maria HelenaORCID,
Barth Afonso Luís,
Martins Andreza Francisco,
Zavascki Alexandre Prehn
Reference20 articles.
1. WHO. Antibiotic resistance. https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance; 2020 [accessed 09.07.23].
2. Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study;Wang;Lancet Infect Dis,2022
3. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine);Paul;Clin Microbiol Infect,2022
4. Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America Antimicrobial-Resistant Treatment Guidance: gram-Negative Bacterial Infections v. 3.0. https://www.idsociety.org/practice-guideline/amr-guidance/; 2023 [accessed 09.07.23].
5. New β-lactam–β-lactamase inhibitor combinations;Yahav;Clin Microbiol Rev,2020